Self-surveillance for genetic predisposition to cancer: Behaviors and emotions

Oncology Nursing Forum

Volumn 33, Issue 2, 2006, Pages 221-231

  Giarelli, Ellen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY WEIGHT; COLON POLYPOSIS; EMOTION; FEEDING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; HEALTH BEHAVIOR; HUMAN; INTERVIEW; MIDDLE AGED; PATIENT COMPLIANCE; PHENOTYPE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUALITY OF LIFE; SELF CARE; SIPPLE SYNDROME;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY WEIGHT; EMOTIONS; FOOD HABITS; GENETIC PREDISPOSITION TO DISEASE; HEALTH BEHAVIOR; HUMANS; INTERVIEWS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PATIENT COMPLIANCE; PHENOTYPE; QUALITATIVE RESEARCH; QUALITY OF LIFE; SELF CARE;

EID: 33646340928     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/06.ONF.221-231     Document Type: Article

References (64)

1. Beeker, C., Kraft, J.M., Southwell, B.G., & Jorgensen, C.M. (2000). Colorectal cancer screening in older men and women: Qualitative research findings and implications for intervention. Journal of Community Health, 25, 263-278.
2. Blalock, S.J., De Vellis, B.M., & Sandler, R.S. (1987). Participation in fecal occult blood screening: A critical review. Preventive Medicine, 16, 9-18.
3. Bliss, J., & Johnson, B. (1995). After diagnosis of cancer: The patient's view of life. International Journal of Palliative Nursing, 1(3), 126-133.
4. Boyatzis, R.E. (1998). Transforming qualitative information: Thematic analysis and code development. Thousand Oaks, CA: Sage.
5. Bussey, H.J.R. (1975). Familial polyposis coli. Family studies, histopathology, differential diagnosis, and results of treatment. Baltimore: Johns Hopkins University Press.
6. Chi, D.D., & Moley, J.F. (1998). Medullary thyroid carcinoma: Genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitonemia. Surgical Oncology Clinics of North America, 7, 681-706.
7. Cleiren, M.P., Oskam, W., & Lips, C.J. (1989). Living with a hereditary form of cancer: Experiences and needs of MEN 2 patients and their families. Henry Ford Hospital Medical Journal, 37, 164-166.
8. Coyle, C. (2002). Familial colorectal cancers-Familial adenomatous polyposis. Retrieved April 26, 2005, from http://www.oncolink.upenn .edu/types/article.cfm?c=5&s=11&ss=82&id=7017
9. Cruz-Correa, M., & Giardiello, F.M. (2002). Diagnosis and management of hereditary colon cancer. Gastroenterology Clinics of North America, 31, 537-549.
10. Easton, D.F., Ponder, M.A., Cummings, T., Gagel, R.F., Hansen, H.H., Reichlin, S., et al. (1989). The clinical and screening age-at-onset distribution for MEN-2 syndrome. American Journal of Human Genetics, 44, 208-215.
11. Fitze, G. (2004). Management of patients with hereditary medullary thyroid carcinoma. European Journal of Pediatric Surgery, 14, 375-383.
12. Frank-Raue, K., Hoppner, W., Buhr, H., Herfarth, C., & Raue, F. (1997). Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy. Experimental and Clinical Endocrinology and Diabetes, 105(Suppl. 4), 76-78.
13. Fry, J.H. (1983). Survey research by telephone. Beverly Hills, CA: Sage.
14. Fryer, A. (2000). Inappropriate genetic testing of children. Archives of Disease in Childhood, 83, 283-285.
15. Giardiello, P.M., Brensinger, J.D., Petersen, G.M., Luce, M.C., Hylind, L.M., Bacon, J.A., et al. (l997). The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. New England Journal of Medicine, 336, 823-827.
16. Giardiello, P.M., Offerhaus, G.J., Lee, D.H., Krush, AJ., Tersmette, A.C., Booker, S.V., et al. (1993). Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut, 34, 1394-1396.
17. Giarelli, E. (2002). Multiple endocrine neoplasia type 2a (MEN2a): A call for psycho-social research. Psycho-Oncology, 1(1), 59-73.
18. Giarelli, E. (2003). Bringing threat to the fore: Participation in lifelong surveillance for genetic risk of cancer. Oncology Nursing Forum, 30, 945-955.
19. Gimm, O., & Dralle, H. (1999). C-cell cancer-Prevention and treatment. Langenbeck's Archives of Surgery, 384, 16-23.
20. Groves, R.M., & Magilavy, L.J. (1981). Increasing response rates to telephone surveys: A door in the face for foot-in-the-door. Public Opinion Quarterly, 45, 346-358.
21. Gurbuz, A.K., Giardiello, F.M., Petersen, G.M., Krush, A.J., Offerhaus, G.J., Booker, S.V., et al. (1994). Desmoid tumors in familial adenomatous polyposis. Gut, 35, 377-381.
22. Halling, K.C., Bufill, J.A., Cotter, M., Artz, S.A., Carpenter, A.B., Schaid, D., et al. (1997). Age-related disease penetrance in a large medullary thyroid cancer family with a codon 609 RET gene mutation. Molecular Diagnosis, 2, 277-286.
23. Harper, P.S., & Clarke, A. (1990). Should we test children for "adult" genetic diseases? Lancet, 335, 1205-1206.
24. Howe, J.R., Lairmore, T.C., Dou, S., Mishra, S.K., Dilley, W.G., Donis-Keller, H., et al. (1992). Presymptomatic identification of carriers of the multiple endocrine neoplasia type 2a gene using flanking DNA markers. Surgery, 112, 219-225.
25. Hyer, W., & Fell, J.M. (2001). Screening for familial adenomatous polyposis. Archives of Disease in Childhood, 84, 377-380.
26. Ishikawa, H. (2004). Chemoprevention of carcinogenesis in familial tumors. International Journal of Clinical Oncology, 9, 299-303.
27. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA: A Cancer Journal for Clinicians, 55, 10-30.
28. Jo, W.S., & Chung, D.C. (2005). Genetics of hereditary colorectal cancer. Seminars in Oncology, 32, 11-23.
29. King, J.E., Dozois, R.R., Lindor, N.M., & Ahlquist, D.A. (2000). Care of patients and their families with familial adenomatous polyposis. Mayo Clinic Proceedings, 75, 57-67.
30. Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science, 253, 661-665.
31. Lairmore, T.C., Frisella, M.M., & Wells, S.A., Jr. (1996). Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma. Annals of Medicine, 28, 401-406.
32. Lal, G., & Gallinger, S. (2000). Familial adenomatous polyposis. Seminars in Surgical Oncology, 18, 314-323.
33. Learoyd, D.L., Marsh, D.J., Richardson, A.L., Twigg, S.M., Delbridge, L., & Robinson, B.G. (1997). Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Archives of Surgery, 132, 1022-1025.
34. Ledger, G.A., Khosla, S., Lindor, N.M., Thibodeau, S.N., & Gharib, H. (1995). Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Annals of Internal Medicine, 122, 118-124.
35. Manning, P.K., & Cullan-Swan, B. (1998). Narrative, content, and semiotic analysis. In N.K. Denzin & Y.S. Lincoln (Eds.), Collecting and interpreting qualitative materials (pp. 246-274). Thousand Oaks, CA: Sage.
36. Matloff, E.T., Brierley, K.L., & Chimera, C.M. (2004). A clinician's guide to hereditary colon cancer. Cancer Journal, 10, 280-287.
37. Matthews, D., & Hingson, R. (1977). Improving patient compliance: A guide for physicians. Medical Clinics of North America, 61, 879-889.
38. Modigliani, E., Vasen, H.M., Raue, K., Dralle, H., Frilling, A., Gheri, R.G., et al. (1995). Pheochromocytoma in multiple endocrine neoplasia type 2: European study. Journal of Internal Medicine, 238, 363-367.
39. Mulligan, L.M., Kwok, J.B., Healy, C.S., Elsdon, M.J., Eng, C., Gardner, E., et al. (1993). Germ-line mutations of the RET proto-oncolgene in multiple endocrine neoplasia syndrome type 2a. Nature, 363, 458-460.
40. Nandakumar, G., Morgan, J.A., Silverberg, D., & Steinhagen, R.M. (2004). Familial polyposis coli: Clinical manifestations, evaluation, management and treatment. Mount Sinai Journal of Medicine, 71, 384-391.
41. National Comprehensive Cancer Network. (2005). Clinical practice guidelines in oncology: Colorectal cancer screening. Retrieved May 27, 2005, from http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening. pdf
42. Neilson, A.R., & Whynes, D.K. (1995). Determinants of persistent compliance with screening for colorectal cancer. Social Science and Medicine, 41, 365-374.
43. Offerhaus, G.J., Giardiello, P.M., Krush, A.J., Booker, S.V., Tersmette, A.C., Kelley, N.C., et al. (1992). The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology, 100, 1980-1982.
44. Pausova, Z., Soliman, E., Amizuka, N., Janicic, N., Konrad, E.M., Arnold, A., et al. (1996). Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2. Journal of Clinical Endocrinology and Metabolism, 81, 2711-2718.
45. Petersen, G.M. (1996). Genetic testing and counseling in familial adenomatous polyposis. Oncology, 10, 89-94.
46. Phillips, R.K., Spigelman, A.D., & Thompson, J.P.S. (Eds.). (1994). Familial adenomatous polyposis and other polyposis syndromes. London: Edward Arnold.
47. Randolph, G.W., & Maniar, D. (2000). Medullary carcinoma of the thyroid. Cancer Control, 7, 253-261.
48. Rhodes, M., & Bradburn, D.M. (1992). Overview of screening and management of familial adenomatous polyposis. Gut, 33, 125-131.
49. Richards, L. ( 1999). Introducing NVivo: A workshop handbook. Melbourne, Australia: QSR International.
50. Richards, T.J., & Richards, L. (1998). Using computers in qualitative research. In N.K. Denzin & Y.S. Lincoln (Eds.), Collecting and interpreting qualitative materials (pp. 211-245). Thousand Oaks, CA: Sage.
51. Rogers, T.F. (1976). Interviews by telephone and in person: Quality of responses and field performance. Public Opinion Quarterly, 40, 51-56.
52. Sabay, T.B., Gray, R.E., & Fitch, M.A. (2000). Qualitative study of patient perspectives on colorectal cancer. Cancer Practice, 8, 38-44.
53. Shields, J.A., Shields, C.L., & Singh, A.D. (2000). Acquired tumors arising from congenital hypertrophy of the retinal pigment epithelium. Archives of Ophthamology, 118, 637-641.
54. Skinner, M.A., DeBenedetti, M.K., Moley, J.F., Norton, J.A., & Wells, S.A., Jr. (1996). Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Journal of Pediatric Surgery, 31, 177-1821.
55. Sondergaard, J.O., Bulow, S., Jarvinen, H., Wolf, J., Witt, I.N., & Tetens, G. (1987). Dental anomalies in familial adenomatous polyposis coli. Acta Odontologica Scandinavia, 45, 61-63.
56. Sprangers, M.A., Taal, B., Aaronson, N.K., & te Velde, A. (1995). Quality of life in colorectal cancer. Stoma vs nonstoma patients. Diseases of the Colon and Rectum, 38, 361-369.
57. Steinbach, G., Lynch, P.M., Phillips, R.K., Wallace, M.H., Hawk, E., Gordon, G.B., et al. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. New England Journal of Medicine, 342, 1946-1952.
58. Strauss, A., & Corbin, S. (1998). Introduction. In Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed., pp. 3-15). Thousand Oaks, CA: Sage.
59. Szubin, L., Kacker, A., Kakani, R., Komisar, A., & Blaugrund, S. (1996). The management of post-thyroidectomy hypocalcemia. Ear, Nose, and Throat Journal, 75, 612-614, 616.
60. Telander, R.L., Zimmerman, D., van Heerden, J.A., & Sizemore, G.W. (1986). Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2a. Journal of Pediatric Surgery, 21, 1190-1194.
61. Telenius-Berg, M., Ponder, M.A., Berg, B., Ponder, B.A., & Werner, S. (1989). Quality of life after bilateral adrenalectomy in MEN 2. Henry Ford Hospital Medical Journal, 37, 160-163.
62. Wells, S.A., Jr., Baylin, S.B., Leight, G.S., Dale, J.K., Dilley, W.G., & Farndon, J.R. (1982). The importance of early diagnosis in patients with hereditary thyroid carcinoma. Annals of Surgery, 195, 596-599.
63. Wells, S.A., Jr., Chi, D.D., Toshima, K., Dehner, L.P., Coffin, C.M., Dowton, S.B., et al. (1994). Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Annals of Surgery, 220, 237-247.
64. Wertz, D.C., Fanos, J.H., & Reilly, P.R. (1994). Genetic testing for children and adolescents. Who decides? JAMA, 272, 875-881.